Luís Filipe Costa Machado has a bachelor degree in Pharmacy (2014) and a master’s degree in Biomedical Research (2015) both from the University of Santiago de Compostela.
In March 2013, he joined the group of neuropharmacology at the University of Bath (UK) where he worked in a research project focused on the study of the genetic bases of depression. During the last months of his undergrad, he also worked at the group of Oncology and Cell Cycle at the Center for Molecular Medicine and Chronic Diseases (CIMUS), to study the role of the transcription factor E2F in neuronal stem cells. During his master’s research project, he joined the group of Stem Cells in Cancer and Aging at the Health Research Institute of Santiago de Compostela (IDIS) where he was responsible for the development of high-throughput methods to identify new senescence inducing compounds in tumor cells.
In December 2015, he joined the group of Bioactive Products and Metabolic Syndrome (BIOPROMET), as a predoctoral researcher, in order to study new approaches to understand and treat metabolic disorders.